3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide has been researched along with n-n-propylnorapomorphine in 1 studies
Studies (3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide) | Trials (3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide) | Recent Studies (post-2010) (3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide) | Studies (n-n-propylnorapomorphine) | Trials (n-n-propylnorapomorphine) | Recent Studies (post-2010) (n-n-propylnorapomorphine) |
---|---|---|---|---|---|
14 | 0 | 6 | 274 | 4 | 12 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dolbeare, K; Gupta, SK; Johnson, RL; Mishra, RK; Pontoriero, GF | 1 |
1 other study(ies) available for 3-(n-prolylamine)-2-oxo-1-pyrrolidineacetamide and n-n-propylnorapomorphine
Article | Year |
---|---|
Iso-lactam and reduced amide analogues of the peptidomimetic dopamine receptor modulator 3(R)-[(2(S)-pyrrolidinylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide.
Topics: Animals; Apomorphine; Cattle; Cell Membrane; Corpus Striatum; Dopamine Agents; In Vitro Techniques; Lactams; Molecular Mimicry; Protein Binding; Pyrrolidinones; Radioligand Assay; Receptors, Dopamine; Structure-Activity Relationship | 2003 |